AQST is trading at $4.30 (+7%) in pre-market sessions, rising from its $4.02 close on May 29, 2026, despite a lack of company-specific news.
- The price action is occurring in thin liquidity, which can often lead to exaggerated moves without a fundamental driver.
- Broader market sentiment is mildly supportive, with U.S. futures and major indices trending higher, though no specific catalyst for Aquestive Therapeutics has been identified.